News Quantified

CTSO – cytosorbents corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

CytoSorbents Rights Offering Begins [Yahoo! Finance]

CytoSorbents Rights Offering Begins

Cytosorbents Co. (NASDAQ: CTSO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week

Cytosorbents Co. (NASDAQ: CTSO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

-18.1%

MISS

5.2%

BEAT

15.0%

IN-LINE

Form 8-K Cytosorbents Corp For: Dec 23

Form 4 Cytosorbents Corp For: Dec 13 Filed by: MARIANI PETER J

Form 4 Cytosorbents Corp For: Dec 11 Filed by: MARIANI PETER J

Form FWP Cytosorbents Corp Filed by: Cytosorbents Corp

Form 424B5 Cytosorbents Corp

Top News Gainers

3/25 CytoSorb® Used to Treat More than 70 Critically-Ill COVID-19 Patients and Specifically Added to Coronavirus Treatment Guidelines in Italy and Panama 29.3%

8/15 CytoSorbents Receives Renewal of CytoSorb® CE Mark Through May 2024 and Annual ISO 13485:2016 Certification Through September 2022 15.8%

3/12 Form 4 Cytosorbents Corp For: Mar 10 Filed by: Capponi Vincent 14.3%

3/31 CytoSorb® Receives Marketing Approval in Mexico with Commercialization to Commence with Partner Fresenius Medical Care 13.7%

4/24 Cytosorbents Corp (NASDAQ: CTSO) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 12.2%

3/9 Cytosorbents Corp (NASDAQ: CTSO) had its "buy" rating re-affirmed by analysts at Dawson James. They now have a price target on the stock, up previously from . 11.1%

3/3 Form 4 Cytosorbents Corp For: Feb 28 Filed by: Jones Edward Raymond 8.2%

3/5 Form 10-K Cytosorbents Corp For: Dec 31 7.7%

4/16 Form 8-K Cytosorbents Corp For: Apr 10 7.4%

12/6 Form 4 Cytosorbents Corp For: Dec 06 Filed by: Chan Phillip P. 7.2%

Top News Decliners

8/6 Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -14.1%

1/28 CytoSorbents latest entry in coronavirus rally; shares up 17% premarket [Seeking Alpha] -12.3%

2/28 CytoSorb Shipment Arrives in Designated Mainland China Hospitals to Treat Cytokine Storm in Critically-ill Patients with COVID-19 Coronavirus Infection -11.5%

4/28 CytoSorbents to Report Q1 2020 Operating and Financial Results -9.8%

3/2 CytoSorbents Highlights Recent Publication Using CytoSorb during Cardiac Surgery for Infective Endocarditits -8.8%

4/29 Cytosorbents: COVID-19 Has Presented A Bullish Opportunity [Seeking Alpha] -8.6%

11/25 CytoSorbents Changes Contract Research Organizations and Temporarily Pauses Enrollment in REFRESH 2-AKI Study -7.4%

2/27 CytoSorbents to Report Fiscal 2019 Operating and Financial Results and to Present at Cowen 40th Annual Healthcare Conference -7.1%

11/5 Q3/2019 9/30/2019 EPS -0.210 ZacksConsensus -0.140 ActVsEst (0.070) - Miss -6.9%

8/26 Form S-8 Cytosorbents Corp -6.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day